A. Sorete Arbore (Iasi, Romania), G. Ferrara (Modena, Italy)
Usefulness of whole blood interferon-γ assay and interferon-γ enzyme-linked immunospot assay for the diagnosis of active tuberculosis
S. K. Han, Y. A. Kang, H. W. Lee, Y. T. Chung, Y. S. Shim, J. J. Yim, H. S. Chung (Seoul, Republic Of Korea)
|  |
Latent tuberculous infection (LTBI) in employees of Geneva University Hospital: estimation of annual risk of infection over a 5-year period
J. P. Janssens, R. Weissbrodt, N. Denereaz-Gonnon, N. Bessire (Geneva, Switzerland)
| |
Usefulness of a daignostic method of tuberculosis infection, QuantiFERON TB-2G, in a contact investigation of medical staffs
Y. Kobashi, M. Fukuda, K. Yoshida, N. Miyashita, M. Oka (Kurashiki, Japan)
| |
Impact of T-SPOT.TB test to exclude active Mycobacterium tuberculosis complex infection in patients with mycobacterial disease
R. M. L. van Leeuwen, A. W. J. Bossink, S. F. T. Thijsen (Utrecht, Netherlands)
| |
Clinical evaluation of a diagnostic method of tuberculosis infection, QuantiFERON TB-2G, for active tuberculosis and nontuberculous mycobacteriosis
Y. Kobashi, M. Fukuda, K. Yoshida, N. Miyashita, M. Oka (Kurashiki, Japan)
| |
Interferon-α and the liver monooxygenas system in patients with pulmonary tuberculosis
T. I. Petrenko, N. S. Kizilova, J. M. Harlamova (Novosibirsk, Russian Federation)
| |
Tuberculosis contact investigation with a new, specific blood test in a low-incidence population
R. Diel, N. Albert, L. Christoph, S. Tom (Duesseldorf, Rotenburg/Wuemme, Hamburg, Borstel, Germany)
| |
The role of the ESAT-6/CFP-10 in whole blood IFN-gamma test in TB assessment
C. Cojocaru, D. Diculencu, T. Mihaescu (Iasi, Romania)
| |
Use of QuantiFERON-TB gold test in diagnosis of active tuberculosis
V. Bartu, E. Kopecka, M. Havelkova, M. Mullerova (Prague, Czech Republic)
| |
The diagnostic value of gama interferon level of pleural effusions in tubercuolus pleurisy
M. Coban Agca, E. Polat, B. Agca, O. Yazicioglu Mocin, T. Karagoz (Istanbul, Turkey)
| |
Plasma stromal derived factor 1 alpha levels in pulmonary tuberculosis
I. Koca, A. Gozu, E. Tansel Putun, N. Kalac, B. Samurkasoglu, H. Simsek (Ankara, Turkey)
| |
Diagnostic values of pleural, γ-IFN and IL 2 levels in tuberculosis pleural effusion
F. Polat, D. Kanmaz, E. Tuncay, E. Yenturk, N. Alkan, Y. Alturk (Istanbul, Turkey)
| |
Advantage of QuantiFERON TB-2G in a contact investigation of tuberculosis infection
K. Takeshita, Y. Suzuki, T. Yamada, A. Takizawa, O. Takeuchi, C. Sato, K. Tsuchimoto (Minato-ku, Japan)
| |
Serum eosinophilia associated with tuberculosis – the incidence and clinical course
T. H. Kim, M. O. Kim, S. D. Lee, D. H. Shin, S. S. Park, H. J. Yoon (Seoul, Jeju, Republic Of Korea)
| |
Tuberculosis associated with TNF-alpha antagonists
M. Seiscento, B. Sidney, S. K. B. Roberta, F. R. Viviane, C. Rafael, L. M. M. Ieda, V. S. Francisco (Sao Paulo, Brazil)
| |
Evaluation of a IFN-γ test using Mycobacterium tuberculosis-specific antigens for diagnosis of active tuberculosis
J. Ruiz-Manzano, J. Dominguez, I. Latorre, M. L. De Souza-Galvao, C. Prat, F. Andreo, N. Rodriguez, L. Haba, C. Ramil, V. Ausina (Badalona, Barcelona, Spain)
| |
Human alveolar macrophages express the chemokin PF-4 in tuberculosis
B. Scheuerer, F. Petersen, N. Reiling, M. Ernst, J. Gerdes, P. Zabel, C. Lange (Borstel, Germany)
| |
Toll-like receptor polymorphisms associated with progression of Mycobacterium tuberculosis infection to pulmonary disease
P. Santos, S. Balseiro, A. Almeida, A. Domingos, A. Segorbe-Luis (Coimbra, Torres Vedras, Portugal)
| |
Study on humeral responses to purified Ag85 M. Bovis
M. Makvandi (Ahwaz, Islamic Republic Of Iran)
| |
Comparison of the tuberculin skin test and the RD1 elispot for the diagnosis of latent tuberculosis infection in renal transplant patients
M. Losi, S. Cerri, D. Davoli, T. Hinks, K. Millington, F. Ferrari, P. Roversi, G. Pollastri, G. Cappelli, V. Malaguti, A. Di Felice, A. Albertazzi, L. M. Fabbri, L. Richeldi, A. Lalvani (Modena, Italy; Oxford, United Kingdom)
| |